2021 Reports
Interim Report Q3
To be released 2021-10-22
Year End Report 2021
To be released 2022-02-23
Annual Report 2021
TBA
Interim Report Q3
To be released 2021-10-22
Year End Report 2021
To be released 2022-02-23
Annual Report 2021
TBA
I-Tech AB is a public held bio-technology company based in Mölndal, Sweden that owns all IP and regulatory rights to the antifouling agent Selektope® (generic name, medetomidine). I-Tech also controls the largest and most efficient source of medetomidine production.
Visit selektope.com
info@i-tech.se
+46 10 30 33 999
I-Tech AB
c/o Astra Zeneca AB
Pepparedsleden 1
SE-431 83 Mölndal
Sweden
